Haplotypes of the alpha‐1 antitrypsin gene in healthy controls and Z deficiency patients
暂无分享,去创建一个
K. Morgan | W. MacNee | N. Kalsheker | T. Guetta-Baranés | S. Chappell | C. O'connor | Kathryn Batowski | E. Yiannakis | T. Guetta‐Baranés
[1] Mark Gerstein,et al. CREB Binds to Multiple Loci on Human Chromosome 22 , 2004 .
[2] J. Taub,et al. Physical and Functional Interactions between USF and Sp1 Proteins Regulate Human Deoxycytidine Kinase Promoter Activity* , 2003, Journal of Biological Chemistry.
[3] V. Hayes. Genetic diversity of the alpha‐1‐antitrypsin gene in Africans identified using a novel genotyping assay , 2003, Human mutation.
[4] M. Nachman,et al. Variation in recombination rate across the genome: evidence and implications. , 2002, Current opinion in genetics & development.
[5] K. Morgan,et al. An alpha1-antitrypsin enhancer polymorphism is a genetic modifier of pulmonary outcome in cystic fibrosis , 2001, European Journal of Human Genetics.
[6] Gonçalo R. Abecasis,et al. GOLD-Graphical Overview of Linkage Disequilibrium , 2000, Bioinform..
[7] B. Seetharam,et al. A 69-Base Pair Fragment Derived from Human Transcobalamin II Promoter Is Sufficient for High Bidirectional Activity in the Absence of a TATA Box and an Initiator Element in Transfected Cells , 1998, The Journal of Biological Chemistry.
[8] D. Lomas,et al. Alpha1-antitrypsin deficiency, cirrhosis and emphysema , 1998 .
[9] J. Sugar,et al. Involvement of Sp1 Elements in the Promoter Activity of the α1-Proteinase Inhibitor Gene* , 1998, The Journal of Biological Chemistry.
[10] S. Rose-John,et al. Oncostatin M, leukaemia-inhibitory factor and interleukin 6 trigger different effects on alpha1-proteinase inhibitor synthesis in human lung-derived epithelial cells. , 1998, The Biochemical journal.
[11] K. Morgan,et al. Mutation in an alpha1-antitrypsin enhancer results in an interleukin-6 deficient acute-phase response due to loss of cooperativity between transcription factors. , 1997, Biochimica et biophysica acta.
[12] J. Spinelli,et al. Mutation in the 3' region of the alpha-1-antitrypsin gene and chronic obstructive pulmonary disease. , 1997, Journal of medical genetics.
[13] R. Crystal,et al. Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy. , 1990, The Journal of clinical investigation.
[14] W. Poller,et al. DNA polymorphisms of the alpha 1-antitrypsin gene region in patients with chronic obstructive pulmonary disease. , 1990, European journal of clinical investigation.
[15] R. Crystal,et al. Molecular basis of alpha-1-antitrypsin deficiency. , 1988, The American journal of medicine.
[16] G. L. Watkins,et al. Deoxyribonucleic acid (DNA) polymorphism of the alpha 1-antitrypsin gene in chronic lung disease. , 1987, British medical journal.
[17] R. Crystal,et al. Identification of a second mutation in the protein-coding sequence of the Z type alpha 1-antitrypsin gene. , 1986, The Journal of biological chemistry.
[18] G. Snider,et al. Effect of combined human neutrophil cathepsin G and elastase on induction of secretory cell metaplasia and emphysema in hamsters, with in vitro observations on elastolysis by these enzymes. , 1985, The American review of respiratory disease.
[19] P. Kilbridge,et al. Expression of the alpha 1-proteinase inhibitor gene in human monocytes and macrophages. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[20] A. Cohen. Interrelationships between the human alveolar macrophage and alpha-1-antitrypsin. , 1973, The Journal of clinical investigation.
[21] Alan D. Lopez. THE GLOBAL BURDEN OF DISEASE 1990-2020 , 2001 .
[22] Alan D. Lopez,et al. The global burden of disease, 1990–2020 , 1998, Nature Medicine.